Watchlist Price Alert

Mereo BioPharma Group (MREO)

NASDAQ: MREO · Real-Time Price · USD

2.65

0.05 (1.92%)

At close: May 02, 2025, 3:59 PM

2.56

-3.58%

After-hours: May 02, 2025, 04:54 PM EDT

Mereo BioPharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017	Q4 2016	Q2 2016
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018	Jun 30, 2018	Dec 31, 2017	Jun 30, 2017	Dec 31, 2016	Jun 30, 2016
Cash & Equivalents	69.8M	80.52M	87.43M	48.66M	57.42M	47.07M	42.11M	n/a	56.33M	61.06M	76.42M	94.3M	110.09M	23.47M	56.82M	16.35M	28.29M	25.04M	34.41M	50.04M	52.08M	53.58M	70.18M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	51.1M	51.1M	n/a	n/a	n/a	n/a	n/a	n/a	7.83M	2.5M	2.5M	2.5M	4.5M	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	1.00	1K	-68.18M	-25.95M	-24.12M	-26.23M	n/a	n/a	n/a	n/a	n/a	n/a	1.00	n/a	n/a	n/a	n/a	n/a
Receivables	3.25M	2.84M	2.67M	2.15M	3.73M	n/a	10.74M	n/a	2.38M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	1.00	1.82M	1.25M	n/a	-2.85M	n/a	-2.38M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-53.62M	n/a
Other Current Assets	129K	464K	2.63M	864K	1.36M	3.56M	4.22M	n/a	1.43M	2.9M	2.65M	2.23M	5.82M	4.64M	8.46M	11.98M	9.7M	5.89M	11.1M	8.66M	5.03M	6.1M	3.83M
Total Current Assets	74.76M	86.72M	93.94M	53.5M	63.76M	52.26M	54.23M	68.18M	62.13M	67.34M	81.81M	99.32M	120.33M	29.73M	66.68M	30.43M	48.88M	34.5M	49.24M	63.18M	63.74M	60.78M	74.76M
Property-Plant & Equipment	984K	1.22M	1.32M	1.47M	1.65M	1.35M	1.56M	n/a	1.83M	1.98M	2.11M	2.53M	2.39M	1.57M	11.22M	11.56M	13.1M	148.93K	152K	153.36K	168.26K	173.87K	189.19K
Goodwill & Intangibles	643K	799K	866K	972K	1.09M	892.61K	24.84M	n/a	24.12M	24.12M	24.12M	24.56M	22.19M	31.65M	31.88M	44.46M	45.16M	32.63M	32.69M	33.01M	25.81M	25.81M	25.81M
Total Long-Term Assets	1.63M	2.02M	2.19M	2.44M	2.74M	2.25M	26.41M	-68.18M	25.95M	1.98M	26.23M	27.09M	24.58M	33.22M	43.1M	56.01M	58.26M	32.78M	32.84M	33.16M	25.98M	25.99M	26M
Total Assets	76.39M	88.75M	96.13M	55.94M	66.5M	54.51M	80.64M	n/a	88.08M	69.32M	108.04M	126.42M	144.92M	62.95M	109.78M	86.45M	107.14M	67.28M	82.08M	96.34M	89.73M	86.76M	100.76M
Account Payables	2.44M	1.75M	2.7M	2.46M	2.35M	1.92M	1.91M	n/a	3.49M	3.13M	2.82M	2.29M	2.19M	2.94M	5.49M	5.88M	6.76M	5.57M	4.98M	2.64M	11.93M	839.19K	5.81M
Deferred Revenue	n/a	2.51M	n/a	3.22M	6.46M	n/a	9.49M	n/a	n/a	n/a	n/a	8.37M	5.46M	n/a	n/a	5.65M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	5.54M	5.55M	4.93M	3.67M	652K	n/a	4.19M	n/a	11.02M	11.93M	15.95M	n/a	n/a	n/a	13.25M	15.14M	8.01M	6.84M	5.64M	1.94M	n/a	n/a	n/a
Other Current Liabilities	2.36M	4.56M	6.04M	1.72M	89K	607.37K	10.64M	n/a	5.82M	1.21M	18.26M	5.62M	6.55M	3.55M	5.2M	684K	5.96M	-2.09M	4.64M	3.67M	3.59M	763.31K	n/a
Total Current Liabilities	13.85M	14.21M	15.47M	11M	9.49M	7.78M	17.46M	n/a	24.68M	21.83M	35.21M	12.54M	9.87M	8.56M	22.37M	29.88M	21.06M	16.18M	14.14M	9.62M	11.93M	3.21M	5.81M
Long-Term Debt	n/a	n/a	n/a	n/a	4.39M	3.6M	3.67M	n/a	n/a	n/a	n/a	14.38M	17.93M	16.14M	14.51M	7.04M	14.85M	14.65M	15.26M	18.81M	1.94M	3.13M	2.96M
Other Long-Term Liabilities	1.39M	1.61M	1.46M	1.37M	1.18M	963.92K	2.21M	-51.4M	54K	140.59K	2.48M	21.66M	55.36M	59.56M	37.5M	24.34M	-4.46M	3.68M	5.53M	5.42M	1.82M	1.17M	1.1M
Total Long-Term Liabilities	1.57M	2M	2.01M	2.1M	6.48M	5.31M	5.43M	-51.4M	1.53M	1.47M	3.24M	25.87M	54.36M	69.35M	63.17M	16.32M	27.05M	18.33M	20.79M	24.23M	3.76M	4.3M	4.06M
Total Liabilities	15.42M	16.21M	17.48M	13.1M	15.96M	13.08M	22.89M	-51.4M	26.21M	23.29M	38.45M	38.41M	64.24M	77.92M	85.54M	46.19M	48.11M	34.51M	34.93M	33.85M	15.69M	7.51M	9.87M
Total Debt	6.43M	6.68M	6.16M	6.02M	5.95M	4.34M	9.31M	n/a	12.77M	13.26M	17.99M	16.76M	20.61M	17.94M	39.82M	32.42M	32.87M	21.48M	20.91M	20.75M	1.94M	3.13M	2.96M
Common Stock	3.06M	3.05M	3.03M	2.77M	2.77M	2.27M	1.93M	n/a	1.88M	2.22M	1.75M	1.75M	1.63M	1.02M	1.02M	294K	293.88K	213.72K	213.44K	213.28K	211.81K	193.02K	193.02K
Retained Earnings	-462.88M	-455.84M	-440.84M	-428.58M	-419.63M	-343.95M	-342.19M	n/a	-331.16M	-362.29M	-316.13M	-296.97M	-297.61M	-309.69M	-270.68M	-146.06M	-127.36M	-111.22M	-96.18M	-79.32M	-56.26M	-33.58M	-19.92M
Comprehensive Income	-18.85M	-11.1M	-18.28M	-18.28M	-17.48M	-14.33M	141.72M	51.4M	137.91M	-19.42M	137.55M	136.9M	81.15M	133.22M	79.62M	47.32M	48.53M	25.59M	24.75M	23.36M	13.37M	12.67M	10.53M
Shareholders Equity	60.97M	72.54M	78.65M	42.84M	50.54M	41.42M	57.74M	51.4M	61.87M	46.03M	69.58M	88M	80.68M	-14.97M	24.24M	40.26M	59.03M	32.77M	47.15M	62.48M	74.04M	79.26M	90.89M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	51.1M	51.1M	n/a	n/a	n/a	n/a	n/a	n/a	7.83M	2.5M	2.5M	2.5M	4.5M	n/a	n/a